Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HBAN vs GSK✓SelectedUSD · GSKHBAN vs GSK performance historyLatest closeAs of-1.54%11/19
Stock and ETF performance explorer

HBAN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+14.5%
GSK return
+39.6%
Excess return
-25.0%
Maximum drawdown
-44.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.5%-1.6%0.0%-1.2%
7D-6.5%-4.7%-1.8%-5.6%
30D-5.3%-4.7%-0.6%-4.5%
3M-13.5%-8.8%-4.7%-12.1%
6M-3.0%-4.6%+1.6%-2.4%
YTD-12.7%+1.0%-13.7%-13.0%
1Y-0.7%+6.9%-7.6%-1.9%
3Y+50.2%+52.5%-2.4%+34.5%
5Y+14.5%+40.3%-25.8%-5.5%
All+14.5%+39.6%-25.0%-5.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling